Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Journal of the International AIDS Society|November 14, 2014
The challenge: streamlining HIV treatment and care while improving outcomesNathan Clumeck
AIDS Reviews|October 29, 2014
Effects of switching to protease inhibitor monotherapy on nucleoside analogue-related adverse eventsNathan Clumeck, Andrew Hill, Christiane Moecklinghoff
AIDS (London, England)|April 22, 2011
Downregulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral loadStéphane De Wit, Marc Delforge, Coca Valentina Necsoi, et al.
The Journal of Antimicrobial Chemotherapy|August 31, 2010
Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trialsBonaventura Clotet, Nathan Clumeck, Christine Katlama, et al.
Journal of the International AIDS Society|March 30, 2011
Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological studyNicolas Dauby, Stéphane De Wit, Marc Delforge, et al.
AIDS (London, England)|December 4, 2004
Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patientsStéphane De Wit, Ronan Boulmé, Bénédicte Poll, et al.
AIDS (London, England)|January 2, 2013
Rilpivirine vs. efavirenz in HIV-1 patients with baseline viral load 100,000 copies/ml or less: week 48 phase III analysisJean-Michel Molina, Nathan Clumeck, Karla Redant, et al.
Nuclear Medicine Communications|March 24, 2009
Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective studyCatherine Castaigne, Marianne Tondeur, Stéphane de Wit, et al.
Pageof 7